Chromatographic assays of drug oxidation by human cytochrome P450 3A4

被引:0
|
作者
Christal D Sohl
Qian Cheng
F Peter Guengerich
机构
[1] Vanderbilt University School of Medicine,Department of Biochemistry and Center in Molecular Toxicology
来源
Nature Protocols | 2009年 / 4卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cytochrome P450 enzymes (P450s) are heme-thiolate mono-oxygenases involved in the oxidation of many endogenous and exogenous substrates. Herein, we describe two protocols for measuring the activity of a key enzyme of drug metabolism, P450 3A4. In this protocol, the substrate is incubated with human liver microsomes, the reaction is quenched, and the substrates and products are extracted and subjected to liquid chromatography (LC) separation and detection. Oxidation of the calcium-channel blocker nifedipine is measured using UV–Vis spectroscopy in-line with high performance liquid chromatography (HPLC). 6β-Hydroxytestosterone formation from testosterone is measured by HPLC coupled to mass spectrometry (MS). Both of these procedures are rapid, requiring 2 h or less, and can be used to confirm and measure P450 3A4 activity and can also be used as a guide for developing other assays for measuring P450 catalysis. The separation strategy described here is more rapid than many available methods, except when ultra-performance liquid chromatography (UPLC) is used.
引用
收藏
页码:1252 / 1257
页数:5
相关论文
共 50 条
  • [31] Interaction of methadone with substrates of human hepatic cytochrome P450 3A4
    Iribarne, C
    Dreano, Y
    Bardou, LG
    Menez, JF
    Berthou, F
    TOXICOLOGY, 1997, 117 (01) : 13 - 23
  • [32] Metabolism of organochlorine pesticides: The role of human cytochrome P450 3A4
    Mehmood, Z
    Williamson, MP
    Kelly, DE
    Kelly, SL
    CHEMOSPHERE, 1996, 33 (04) : 759 - 769
  • [33] Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions
    Tang, W
    Stearns, RA
    CURRENT DRUG METABOLISM, 2001, 2 (02) : 185 - 198
  • [34] Antiplatelet Drug Resistance and Drug-Drug Interactions: Role of Cytochrome P450 3A4
    Wei C. Lau
    Paul A. Gurbel
    Pharmaceutical Research, 2006, 23 : 2691 - 2708
  • [35] Antiplatelet drug resistance and drug-drug interactions: Role of cytochrome p450 3A4
    Lau, Wei C.
    Gurbel, Paul A.
    PHARMACEUTICAL RESEARCH, 2006, 23 (12) : 2691 - 2708
  • [36] Multivariate modeling of cytochrome P450 3A4 inhibition
    Kriegl, JM
    Eriksson, L
    Arnhold, T
    Beck, B
    Johansson, E
    Fox, T
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 24 (05) : 451 - 463
  • [37] Polymorphism in Cytochrome P450 3A4 Is Ethnicity Related
    Guttman, Yelena
    Nudel, Adi
    Kerem, Zohar
    FRONTIERS IN GENETICS, 2019, 10
  • [38] Role of Cytochrome P450 3A4 in Cancer Drug Resistance: Challenges and Opportunities
    Pandey, Swaroop Kumar
    Verma, Sona
    Upreti, Shobha
    Mishra, Anuja
    Yadav, Neha
    Dwivedi-Agnihotri, Hemlata
    CURRENT DRUG METABOLISM, 2024, 25 (04) : 235 - 247
  • [39] EXPRESSION AND CHARACTERIZATION OF CYNOMOLGUS CYTOCHROME P450 3A4
    Subramanian, Murali
    Bhutani, Priyadeep
    Selvakumar, Sindhuja
    Ghosh, Kaushik
    Krishnamurthy, Prasad
    Rami, Bhadresh
    Kallipatti, Sanjith
    Sukrutharaj, Sunil
    Selvam, Sabariya
    Halan, Vivek
    Ramarao, Manjunath
    Mandlekar, Sandhya
    DRUG METABOLISM REVIEWS, 2014, 45 : 89 - 89
  • [40] Cooperativity in oxidations catalyzed by cytochrome P450 3A4
    Ueng, YF
    Kuwabara, T
    Chun, YJ
    Guengerich, FP
    BIOCHEMISTRY, 1997, 36 (02) : 370 - 381